Biomimetic Innovation Ltd is an affiliate of PBC Biomed; a medical device company involved in design, development and manufacturing headquartered in Shannon, Ireland and with offices in Memphis, Tennessee and Chamonix, France. Its mission is to accelerate medical innovation through the development of a new bone adhesive technology based on biology called OsStic™. Resulting from a decade long collaboration between GP Bio Ltd and PBC Biomed Ltd, both with extensive expertise in the area of biomaterials and bone repair, Biomimetic Innovations aims to commercialise OsStic™ in a multitude of applications as a biomimetic adhesive for skeletal and soft tissue repair.
Strengthening the Bond: A breakthrough bioadhesive designed to mimic the bodies' natural healing process.
OsStic™ was designed to work with the body’s natural healing process. The technology is being studied for Bone Void Filling/Bone Defect’s applications in human and veterinary medicine to help overcome current surgical challenges. By supporting the body’s own repair pathways, OsStic™ has the potential to improve outcomes across a variety of surgical procedures.
OsStic™ Benefits Clinicians & Patients
Based on extensive in-vivo studies, OsStic™ offers trauma, spinal and dental clinicians and their patients, the opportunity to benefit from the disruptive attributes of this technology.
OsStic™ Receives FDA 'Breakthrough Device' Designation in 2023
OsStic™ Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects to enhance structural stability where standard fixation alone cannot provide sufficient support for functional mobilization.
Contact Us
Have Questions? We’re Here to Help
Direct Message
PBC BioMed
